Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Inc. ( an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful ...

Qatar is to adopt the Cardio4cities approach – a data-driven cardiovascular population health initiative – and become the ...

Enliven Therapeutics (ELVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sam ...

The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

CARDIO4Cities is developed and tested by the Novartis Foundation and it uses data to help policymakers develop better ...

Researchers from organizations with new access to Truveta Data include American Heart Association, Bayer, Edwards Lifesciences, Eli Lilly and Co., Gates Ventures, GORE, Impulse Dynamics, Indiana ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...